DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Navelbine (Vinorelbine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Navelbine (Vinorelbine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (108)
Death (23)
Life Threatening Events (2)
Disability (1)

Reports by Reaction Type

Febrile Neutropenia (10)Confusional State (8)Tachycardia (8)Tongue Neoplasm Malignant Stage Unspecified (8)Diarrhoea (7)Neoplasm Progression (6)Pyrexia (6)Pleural Effusion (6)Cardiotoxicity (6)Neutropenia (6)Chills (5)White Blood Cell Count Decreased (5)

Below are a few examples of reports where side effects / adverse reactions may be related to Navelbine (Vinorelbine). For a complete list or a specific selection of reports, please use the links above.

Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from China on 2012-08-23

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Myalgia, Bone Pain, Intestinal Obstruction

Drug(s) suspected as cause:
Navelbine
    Indication: Neoplasm Malignant
    Start date: 2009-11-03

Xeloda
    Administration route: Oral
    Indication: Neoplasm Malignant
    Start date: 2009-11-03
    End date: 2009-11-08



Possible Navelbine side effects in 77 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24

Patient: 77 year old male

Reactions: Joint Instability, Myalgia, Parkinson's Disease, Dizziness, Dysaesthesia, Fall, Paraesthesia

Drug(s) suspected as cause:
Atorvastatin
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    End date: 2012-01-04

Carboplatin
    Dosage: first cycle, day 1
    Indication: Lung Neoplasm Malignant
    Start date: 2011-01-01

Carboplatin
    Dosage: second cycle
    Start date: 2011-12-14
    End date: 2011-12-14

Navelbine
    Dosage: second cycle
    Start date: 2011-12-14
    End date: 2011-12-21

Navelbine
    Dosage: first cycle, days 1 and 8
    Indication: Lung Neoplasm Malignant
    Start date: 2011-01-01



Possible Navelbine side effects in 64 year old female

Reported by a individual with unspecified qualification from Italy on 2012-07-24

Patient: 64 year old female

Reactions: Diarrhoea, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 40 mg unk, iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-09

Navelbine
    Dosage: 37.5 mg, unk, iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-15

Other drugs received by patient: Glutathione Sodiuim; Desamethasone Fost



Possible Navelbine side effects in female

Reported by a consumer/non-health professional from France on 2012-07-10

Patient: female

Reactions: Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2009-02-01

Aromasin
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2007-02-01

Cyclophosphamide
    Start date: 2004-12-03
    End date: 2005-02-02

Cyclophosphamide
    Administration route: Oral
    Start date: 2011-02-01

Doxorubicin HCL
    Start date: 2007-11-27
    End date: 2009-11-05

Epirubicin Hydrochloride
    Start date: 2004-12-03
    End date: 2005-05-02

Estracyt / 00327002 /
    Start date: 2009-12-03
    End date: 2011-01-01

Faslodex / 01503001 /
    Administration route: Oral
    Start date: 2007-02-01
    End date: 2007-05-01

Femara
    Administration route: Oral
    Start date: 2005-04-01
    End date: 2006-11-01

Fluorouracil
    Start date: 2004-12-03
    End date: 2005-02-02

Navelbine
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Administration route: Oral
    Start date: 2007-07-01
    End date: 2007-11-01

Taxotere
    Start date: 2005-03-08
    End date: 2005-04-19

Xeloda
    Administration route: Oral
    Start date: 2007-08-01
    End date: 2007-11-01



Possible Navelbine side effects in 66 year old female

Reported by a consumer/non-health professional from United States on 2012-07-10

Patient: 66 year old female

Reactions: Metastasis, Malaise, Tumour Marker Increased, Drug Ineffective, Neoplasm Progression

Drug(s) suspected as cause:
Avastin
    Indication: Product Used FOR Unknown Indication

Herceptin

Herceptin
    Indication: Breast Cancer Metastatic

Navelbine

Navelbine
    Dosage: freq: every other week
    Indication: Breast Cancer



Possible Navelbine side effects in 903 month old female

Reported by a physician from France on 2012-07-05

Patient: 903 month old female

Reactions: Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-01-01
    End date: 2009-02-01

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2006-11-01
    End date: 2007-02-01

Cyclophosphamide
    Start date: 2004-12-03
    End date: 2005-05-02

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2011-02-01

Cyclophosphamide
    Start date: 2011-08-02

Doxorubicin HCL
    Dosage: 17 courses of chemotherapy
    Indication: Breast Cancer
    Start date: 2007-11-27
    End date: 2009-11-05

Epirubicin Hydrochloride
    Dosage: 4 courses of chemotherapy
    Indication: Breast Cancer
    Start date: 2004-12-03
    End date: 2005-05-02

Estracyt
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2009-12-03
    End date: 2011-01-01

Faslodex
    Indication: Breast Cancer
    Start date: 2007-02-01
    End date: 2007-05-01

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2005-04-01
    End date: 2006-11-01

Fluorouracil
    Dosage: 4 courses of chemotherapy
    Indication: Breast Cancer
    Start date: 2004-12-03
    End date: 2005-02-02

Navelbine
    Dosage: 4 courses of chemotherapy 90 mg from day 1 to day 8
    Indication: Breast Cancer
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Dosage: 4 courses of chemotherapy
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-07-01
    End date: 2007-11-01

Taxotere
    Dosage: 3 courses of chemotherapy
    Indication: Breast Cancer
    Start date: 2005-03-08
    End date: 2005-04-19

Xeloda
    Dosage: 4 courses of chemotherapy
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-08-01
    End date: 2007-11-01



Possible Navelbine side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-03

Patient: 61 year old male

Reactions: Hypersensitivity, Pleural Effusion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Navelbine

Other drugs received by patient: Carvedilol; Tarceva; Rocaltrol; Candesartan Cilexetil; Ticlopidine HCL; Rabeprazole Sodium; Sevelamer Hydrochloride; Aldomet; Kalimate; Calcium Lactate; Glakay



Possible Navelbine side effects in

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-03

Patient:

Reactions: Haemoptysis

Drug(s) suspected as cause:
Navelbine

Other drugs received by patient: Bevacizumab; Cisplatin



Possible Navelbine side effects in 75 year old female

Reported by a physician from France on 2012-07-03

Patient: 75 year old female

Reactions: Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2008-01-01
    End date: 2009-02-01

Aromasin
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2006-11-01
    End date: 2007-02-01

Cyclophosphamide
    Dosage: unk
    Start date: 2011-08-02

Cyclophosphamide
    Dosage: 4 cycles
    Indication: Breast Cancer Metastatic
    Start date: 2004-12-03
    End date: 2005-02-02

Doxorubicin HCL
    Dosage: 8 courses
    Indication: Breast Cancer Metastatic
    Start date: 2007-11-27
    End date: 2008-06-24

Doxorubicin HCL
    Dosage: 9 courses
    Start date: 2009-02-19
    End date: 2009-11-05

Epirubicin Hydrochloride
    Dosage: 4 cycles
    Indication: Breast Cancer Metastatic
    Start date: 2004-12-03
    End date: 2005-05-02

Estracyt
    Dosage: 2 df, 2x/day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2009-12-03
    End date: 2011-01-01

Faslodex
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-02-01
    End date: 2007-05-01

Femara
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2005-04-01
    End date: 2006-11-01

Fluorouracil
    Dosage: 4 cycles
    Indication: Breast Cancer Metastatic
    Start date: 2004-12-03
    End date: 2005-02-02

Navelbine
    Dosage: 90 mg, 4 courses, cyclic, day 1-8
    Indication: Breast Cancer Metastatic
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Dosage: 4 cycles
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-07-01
    End date: 2007-11-01

Taxotere
    Dosage: 3 cycles
    Indication: Breast Cancer Metastatic
    Start date: 2005-03-08
    End date: 2005-04-19

Xeloda
    Dosage: 4 cycles
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-08-01
    End date: 2007-11-01



Possible Navelbine side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-03

Patient: 71 year old male

Reactions: Pneumonia, Cardio-Respiratory Arrest, Haemoptysis, Platelet Count Decreased, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Navelbine

Other drugs received by patient: Dexamethasone Sodium Phosphate; Magmitt; Epinastine Hydrochloride



Possible Navelbine side effects in 64 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-03

Patient: 64 year old female

Reactions: Diarrhoea, Febrile Neutropenia, RED Blood Cell Sedimentation Rate Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 40 mg unk iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-09

Navelbine
    Dosage: 37.5 mg unk iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-15

Other drugs received by patient: Glutathione Sodium; Desametasone Fosf



Possible Navelbine side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-03

Patient: 65 year old male

Reactions: Pulmonary Embolism

Drug(s) suspected as cause:
Cisplatin
    Indication: Lung Adenocarcinoma

Navelbine
    Indication: Lung Adenocarcinoma



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-02

Patient: female

Reactions: Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2009-02-01

Aromasin
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2007-02-01

Cyclophosphamide
    Start date: 2004-12-03
    End date: 2005-02-02

Doxorubicin HCL
    Start date: 2007-11-27
    End date: 2009-11-05

Epirubicin Hydrochloride
    Start date: 2004-12-03
    End date: 2005-05-02

Estracyt / 00327002 /
    Start date: 2009-12-03
    End date: 2011-01-01

Femara
    Administration route: Oral
    Start date: 2005-04-01
    End date: 2006-11-01

Fluorouracil
    Start date: 2004-12-03
    End date: 2005-02-02

Fulvestrant
    Administration route: Oral
    Start date: 2007-02-01
    End date: 2007-05-01

Navelbine
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Administration route: Oral
    Start date: 2007-07-01
    End date: 2007-11-01

Taxotere
    Start date: 2005-03-08
    End date: 2005-04-19

Xeloda
    Administration route: Oral
    Start date: 2007-08-01
    End date: 2007-11-01



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-02

Patient: female

Reactions: Drug Intolerance, Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-01-01
    End date: 2009-02-01

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-11-01
    End date: 2007-02-01

Cyclophosphamide
    Dosage: 14 days on 21 days
    Indication: Breast Neoplasm
    Start date: 2011-02-01

Doxorubicin HCL
    Dosage: 9 courses
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-02-19
    End date: 2009-11-05

Doxorubicin HCL
    Dosage: 8 courses
    Start date: 2007-11-27
    End date: 2008-06-24

Estracyt
    Administration route: Oral
    Start date: 2009-12-03
    End date: 2011-01-01

Estracyt
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-08-02

Faslodex
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-02-01
    End date: 2007-05-01

Femara
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-11-01

Navelbine
    Dosage: at day 1 and day 8 per course 4 course
    Indication: Metastases To Pleura
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Dosage: 4 courses
    Administration route: Oral
    Indication: Metastases To Pleura
    Start date: 2007-07-01
    End date: 2007-11-01

Xeloda
    Dosage: 4 courses
    Administration route: Oral
    Indication: Metastases To Pleura
    Start date: 2007-07-01
    End date: 2007-11-01



Possible Navelbine side effects in 75 year old female

Reported by a physician from France on 2012-06-29

Patient: 75 year old female

Reactions: Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2008-01-01
    End date: 2009-02-01

Aromasin
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2006-11-01
    End date: 2007-02-01

Cyclophosphamide
    Indication: Breast Cancer Metastatic
    Start date: 2004-12-03
    End date: 2005-02-02

Doxorubicin HCL
    Indication: Breast Cancer Metastatic
    Start date: 2007-11-27
    End date: 2009-11-05

Epirubicin Hydrochloride
    Indication: Breast Cancer Metastatic
    Start date: 2004-12-03
    End date: 2005-05-02

Estracyt
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2009-12-03

Faslodex
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-02-01
    End date: 2007-05-01

Femara
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2005-04-01
    End date: 2006-11-01

Fluorouracil
    Indication: Breast Cancer Metastatic
    Start date: 2004-12-03
    End date: 2005-02-02

Navelbine
    Indication: Breast Cancer Metastatic
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-07-01
    End date: 2007-11-01

Taxotere
    Indication: Breast Cancer Metastatic
    Start date: 2005-03-08
    End date: 2005-04-19

Xeloda
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-11-01
    End date: 2007-11-01



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-28

Patient: female

Reactions: General Physical Condition Abnormal, Drug Intolerance, Recurrent Cancer, Toxicity To Various Agents, Tongue Neoplasm Malignant Stage Unspecified, Metastases To Skin, Treatment Failure, Metastases To Pleura, Metastases To Bone, Metastases To Lung

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Dosage: 1 dosage forms;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-01-01
    End date: 2009-02-01

Aromasin
    Dosage: 1 dosage forms;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2006-11-01
    End date: 2007-02-01

Cyclophosphamide
    Dosage: 4 courses
    Indication: Breast Cancer
    Start date: 2004-12-03
    End date: 2005-02-02

Doxorubicin HCL
    Dosage: 17 courses
    Indication: Breast Cancer
    Start date: 2007-08-27
    End date: 2009-11-05

Epirubicin Hydrochloride
    Dosage: 4 courses
    Indication: Breast Cancer
    Start date: 2004-12-03
    End date: 2005-05-02

Estracyt
    Dosage: 4 dosage forms;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2009-12-03
    End date: 2011-01-01

Faslodex
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-02-01
    End date: 2007-05-01

Femara
    Dosage: 1 dosage forms;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2005-04-01
    End date: 2006-11-01

Fluorouracil
    Dosage: 4 courses
    Indication: Breast Cancer
    Start date: 2004-12-03
    End date: 2005-02-02

Navelbine
    Dosage: 90mg on day 1 and 8, 4 courses
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Dosage: 4 courses
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-07-01
    End date: 2007-11-01

Taxotere
    Dosage: 3 courses
    Indication: Breast Cancer
    Start date: 2005-03-08
    End date: 2005-04-19

Xeloda
    Dosage: 4 courses
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-08-01
    End date: 2007-11-01



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-28

Patient: female

Reactions: Lymphadenopathy, Tongue Disorder, Bronchial Disorder, General Physical Health Deterioration, Metastases To Pleura, Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Dosage: 1 df, daily
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2009-02-01

Cyclophosphamide
    Start date: 2004-12-03

Cyclophosphamide
    Start date: 2011-02-01

Cyclophosphamide
    Start date: 2011-02-02

Doxorubicin HCL
    Start date: 2007-11-27
    End date: 2008-06-24

Doxorubicin HCL
    Start date: 2009-02-19
    End date: 2009-11-05

Epirubicin Hydrochloride
    Start date: 2004-12-02
    End date: 2005-02-02

Estracyt
    Dosage: 2 df, twice daily
    Administration route: Oral
    Start date: 2009-12-03
    End date: 2011-01-01

Exemestane
    Dosage: 1 df, daily
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2007-02-01

Faslodex
    Administration route: Oral
    Start date: 2007-02-01
    End date: 2007-05-01

Femara
    Dosage: 1 df, daily
    Start date: 2005-04-01
    End date: 2006-11-01

Fluorouracil
    Start date: 2004-12-03
    End date: 2005-02-02

Navelbine
    Dosage: 90 mg, unk
    Start date: 2007-07-01
    End date: 2007-11-01

Navoban
    Administration route: Oral
    Start date: 2007-07-01
    End date: 2007-11-01

Xeloda
    Administration route: Oral
    Start date: 2007-08-01
    End date: 2007-11-01



Possible Navelbine side effects in 64 year old female

Reported by a physician from Italy on 2012-06-27

Patient: 64 year old female

Reactions: Diarrhoea, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 50mg/100ml (cyclical)
    Indication: Lung Adenocarcinoma
    Start date: 2011-06-08
    End date: 2011-06-09

Navelbine
    Dosage: 37.5 (10 mg/ml,cyclical)
    Indication: Lung Adenocarcinoma
    Start date: 2011-06-08
    End date: 2011-06-15

Other drugs received by patient: Desametasone Fosfato Hospira; Glutatione Sodico



Possible Navelbine side effects in 63 year old male

Reported by a physician from France on 2012-06-25

Patient: 63 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Acute Myeloid Leukaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cisplatin
    Dosage: 145 mg, cyclic
    Indication: Neoplasm Malignant
    Start date: 2008-02-01
    End date: 2008-05-01

Navelbine
    Dosage: 55 mg, day 1 to day 8
    Indication: Neoplasm Malignant
    Start date: 2008-02-01
    End date: 2008-05-01

Tarceva
    Dosage: 25 mg, uid/qd
    Administration route: Oral
    Indication: Neoplasm Malignant
    Start date: 2008-10-01
    End date: 2012-04-28



Possible Navelbine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-25

Patient: male

Reactions: Eyelid Oedema, Face Oedema, Chills, Tachycardia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar
    Indication: Hodgkin's Disease
    Start date: 2012-04-30

Ifosfamide
    Indication: Hodgkin's Disease

Navelbine
    Indication: Hodgkin's Disease
    Start date: 2012-04-30



Possible Navelbine side effects in 76 year old male

Reported by a physician from United Kingdom on 2012-06-22

Patient: 76 year old male, weighing 96.0 kg (211.2 pounds)

Reactions: Constipation, Ileus Paralytic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-20

Navelbine
    Dosage: 55mg/m2
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-20



Possible Navelbine side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-21

Patient: female

Reactions: White Blood Cell Count Decreased, Back Pain, Pain in Extremity, Therapeutic Response Unexpected, Palmar-Plantar Erythrodysaesthesia Syndrome, Headache, Metastases To Spine, Musculoskeletal Stiffness, Brain Neoplasm

Drug(s) suspected as cause:
Herceptin
    Dosage: first therapy of herceptin

Herceptin
    Start date: 2012-01-01

Herceptin
    Indication: Breast Cancer
    Start date: 2012-01-12

Herceptin
    Start date: 2012-01-01

Herceptin
    Dosage: reduction frequency
    Start date: 2012-01-01

Herceptin
    Start date: 2012-01-01

Navelbine
    Indication: Breast Cancer

Navelbine
    Dosage: dose reduce three weeks on adnone week off

Taxol
    Indication: Breast Cancer

Tykerb
    Indication: Breast Cancer
    Start date: 2009-12-01

Xeloda
    Dosage: two week on and one week off.
    Indication: Breast Cancer
    Start date: 2009-12-01

Xeloda
    Start date: 2010-11-01



Possible Navelbine side effects in female

Reported by a physician from Germany on 2012-06-20

Patient: female

Reactions: Tinnitus, Visual Impairment, Dizziness

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer

Herceptin
    Dosage: 11 cycle
    Start date: 2012-04-24

Navelbine
    Indication: Breast Cancer
    End date: 2011-12-01

Other drugs received by patient: Jodid; Junik; Serevent; Eunova; Lisinopril; Trimipramine Maleate; Acetaminophen



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-15

Patient: female

Reactions: Spinal Cord Compression, Thrombophlebitis, Injection Site Pain

Drug(s) suspected as cause:
Carboplatin
    Dosage: intravenous (not otherwise specified)
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-24

Navelbine
    Dosage: intravenous (not otherwise specified)
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-24



Possible Navelbine side effects in 72 year old female

Reported by a physician from Israel on 2012-06-13

Patient: 72 year old female

Reactions: Multi-Organ Failure, Renal Failure, Pneumonia, Sepsis, Atrial Fibrillation, Pyrexia, Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Navelbine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Trastuzumab
    Indication: Breast Cancer



Possible Navelbine side effects in female

Reported by a physician from United Kingdom on 2012-06-08

Patient: female

Reactions: Thrombophlebitis

Drug(s) suspected as cause:
Carboplatin
    Indication: non-Small Cell Lung Cancer

Navelbine
    Indication: non-Small Cell Lung Cancer



Possible Navelbine side effects in 14 year old female

Reported by a physician from United States on 2012-06-07

Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Atelectasis, Hypotension, Pleural Effusion, Febrile Neutropenia, Hypoxia, Pneumonitis, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: day 1 over 30-60 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-14

Navelbine
    Dosage: days 1 and 8, over 6-10 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-01
    End date: 2012-02-21

Temsirolimus
    Dosage: days 1, 8 and 15 over 30-60 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-28



Possible Navelbine side effects in 45 year old female

Reported by a physician from Taiwan, Province of China on 2012-06-06

Patient: 45 year old female

Reactions: Pleural Effusion, Metastases To Bone, Metastases To Central Nervous System

Drug(s) suspected as cause:
Herceptin
    Start date: 2009-06-08
    End date: 2009-09-08

Herceptin
    Start date: 2009-09-29
    End date: 2010-07-08

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2009-06-01
    End date: 2009-06-01

Navelbine
    Administration route: Oral
    Start date: 2009-12-29
    End date: 2010-02-09

Navelbine
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2009-12-21
    End date: 2009-12-21

Taxotere
    Start date: 2009-09-29
    End date: 2009-12-01

Taxotere
    Indication: Breast Cancer Metastatic
    Start date: 2009-06-01
    End date: 2009-07-27

Xeloda
    Indication: Breast Cancer Metastatic
    Start date: 2010-03-02
    End date: 2010-07-20



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06

Patient: female, weighing 12.7 kg (27.9 pounds)

Reactions: Mucosal Inflammation, Fungaemia, Febrile Neutropenia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Cyclophosphamide
    Dosage: 11 mg
    Administration route: Oral
    Indication: Rhabdomyosarcoma
    Start date: 2012-03-01

Dactinomycin
    Dosage: day 1 of cycle
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Doxorubicin HCL
    Dosage: days 1 and 2
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Ifosfamide
    Dosage: dadys 1 and 2
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Mesna
    Start date: 2011-09-21

Mesna

Mesna
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Navelbine
    Indication: Rhabdomyosarcoma
    Start date: 2012-03-01

Vincristine
    Dosage: days 1, 8 and 15 of cycle
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Other drugs received by patient: Ondansetron; Ondansetron; Levomepromazine; Docusate; Gentamycin Sulfate; Piperacillin and Tazobactam; Ondansetron; Neupogen; Levomepromazine; Docusate; Fluconazole; Docusate; Dihydrocodeine Bitartrate INJ; Ondansetron; Movicol / 01625101 /; Movicol / 01625101 /; Neupogen; Acetaminophen; Morphine; Movicol / 01625101 /; Cotrim



Possible Navelbine side effects in 79 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-04

Patient: 79 year old female

Reactions: Blood Pressure Increased, Vertigo

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Naloxone
    Dosage: 5 mg tid
    Indication: Pain
    Start date: 2012-03-21
    End date: 2012-03-28

Navelbine
    Dosage: 2 mg iv
    Indication: Breast Cancer
    Start date: 2012-03-21
    End date: 2012-03-21

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012